Clarapath, a White Plains, NY-based medical robotics company modernizing and transforming how pathology laboratories process tissue, raised $36m in Series B-1 funding.
The round was led by Northwell Ventures with participation from CU Healthcare Innovation Fund, Mayo Clinic, and Ochsner Ventures.
The company intends to use the funds to further accelerate the commercialization of SectionStar™, to expand its sales and service, precision manufacturing capabilities as well as continue its R&D pipeline.
Led by Eric Feinstein, CEO, Clarapath is a medical robotics company aimed at catalyzing change in the way pathology laboratories work. Its SectionStar is a (pending US launch) all-in-one tissue sectioning and transfer system that increases capacity, reliability, and consistency while minimizing the need for highly skilled labor. The company is headquartered and runs its medical device development in Hawthorne, NY. It has a CLIA-certified laboratory that serves clinical and non-clinical organizations.
FinSMEs
24/07/2024